Purpose of review Diarrheal disease causes substantial morbidity and mortality worldwide; however, defining the microbiologic causes are challenging due to the large number of potential enteropathogens that require testing, insensitivity of existing conventional methods, the frequent occurrence of mixed infections, and high rates of background carriage in many communities.
Introduction
Diarrheal disease causes a substantial burden of morbidity and mortality worldwide. It is estimated that diarrhea kills 1.5 million children each year, or 15% of attributable deaths [1, 2] . Beyond mortality, morbidity from diarrheal diseases exacts an enormous global public health burden through growth faltering, malnutrition, and cognitive impairment [3] . Developed countries also experience a substantial healthcare burden due to diarrheal disease. In the United States alone an estimated $6 billion is lost annually for medical expenses and diminished productivity [4] . For all of these reasons, ascertaining the causes of diarrhea are important in order to guide global health interventions, direct public health efforts in cases of outbreak situations, and care for patients.
Unfortunately, there is no gold standard for the etiologic cause of diarrhea. The list of enteropathogens that can cause diarrhea is long and includes viruses, bacteria, protozoa, and helminths [4] [5] [6] . Even in the bestequipped clinical laboratories not every enteropathogen can be routinely tested. Furthermore, detection does not denote disease, as virtually all enteropathogens can exist asymptomatically or subclinically, particularly in developing country settings. Thus the interpretation of a detected enteropathogen in a stool sample of an individual with diarrhea must be made cautiously, as our detection schemes can never be completely comprehensive and detected pathogens may not be the causative ones. In this context, this review will describe evolving strategies to discern the causes of diarrhea.
The clinical-laboratory context
The clinical context of the individual remains critically important before laboratory testing for causes of diarrhea. This is because no matter how perfect the diagnostic test, Bayes' theorem holds that the posttest probability (e.g. of an infection causing diarrhea) will depend equally on the pretest probability (e.g. clinical likelihood) and the diagnostic test's performance [4, 7] .
Upon laboratory testing of stool there are several possible outcomes (Fig. 1) . The most common result in most settings is that no pathogen is identified. There are several interpretations of this result, highlighted in the figure, one of which is that the pathogen was present in the stool sample but was below the limit of detection of the assay. Stool is a complex matrix of commensal and potentially pathogenic microbes, and finding a rare enteropathogen is inherently challenging. For example, one study estimated values as low as 10 7 and as high as 10 10 microbes per gram (dry weight) of stool, depending on the microbial species [8] . In particular, culture for bacteria can be hampered by prior or concurrent use of antimicrobials [9] or overgrowth of commensals. The other possible outcome is that one or more potential pathogens are detected. When this occurs one should always ask what is the background rate of detection of the enteropathogen in the particular setting [10] [11] [12] , as in many settings enteropathogens can be carried asymptomatically. This background detection rate depends on setting, organism, and test, and is particularly high in children in developing countries and when highly sensitive molecular techniques are used [5] . For example, in a Defining the causes of diarrhea Operario and Houpt 465
Key points
Defining the cause of any case of diarrhea is complicated by a large list of potential enteropathogens, insensitivity of current conventional methods, occurrence of mixed infections, and appreciable rates of background carriage. Newer detection methods, especially multiplexed and quantitative PCR, have the capability to enumerate multiple pathogens and define the relative amounts in a single stool sample. study in Bangladesh, 18% of patients without diarrhea were found to be positive for Giardia by antigen detection [13] .
Laboratory methods
Although most of this review will focus on newer molecular methods, a brief discussion on traditional culture methods is warranted. Culture protocols involve multiple selective media and reagents, usually for diarrheagenic Escherichia coli, Salmonella, Shigella, and Campylobacter, followed by identification of colonies by appearance, biochemical testing, or molecular probes. Culture is impaired by antibiotic use and is frequently of low yield for identifying an enteropathogen instance [14] . Microscopy is used primarily for parasites, entails concentration methods and staining for morphologic detail, and depends on skilled microscopists. Antigen detection has greatly advanced the detection of enteropathogens by offering stable quality-controlled kits that can be used across laboratories. Such tests are available for protozoa (e.g. Entamoeba histolytica, Cryptosporidium, Giardia), viruses (e.g. rotavirus, astrovirus, adenovirus, norovirus), and bacterial products (e.g. Clostridium difficile toxins, Shiga toxin, Campylobacter). They can be costly and their performance depends on good quality capture and detection antibodies (e.g. low sensitivity for norovirus [15] ).
Nucleic acid amplification techniques for the detection of diarrhea-causing agents have become widespread. Table 1 presents a nonexhaustive list of selected singleplex and multiplexed PCR assays for the detection of diarrheagenic organisms published over the previous several years. We focused on assays that demonstrated sensitivity improvements over conventional assays, highly multiplexed assays for several pathogens, and assays that yielded quantitative results. Most were performed only in research laboratories. These are generally more sensitive than culture, microscopy, or antigen detection as detailed. In one example, a study describing a real-time PCR assay designed to detect E. intestinalis reported a lower limit of detection of as little as 10 2 spores/ml stool, an improvement over detection by staining and microscopy (10 6 spores/ml stool) [16] . In another example, PCR methods increased the detection of pathogens over conventional methods from 53% to 75% in cases and from 19% to 42% in healthy controls amongst 4627 samples tested [10] . In a final example, employment of PCR methods resulted in a 22-fold increase in the detection Cryptosporidium and Giardia species vs. conventional microscopy [17] . Many are capable of differentiating species (e.g. Cryptosporidium hominis vs. C. parvum) or pathogen subtypes (e.g. diarrheagenic E. coli subtypes) that are impossible to distinguish by morphology. The specificity of PCR is also high, particularly when internal sequence-specific probes are used to confirm detection. These methods are rapid, with the ability to return clinically relevant results in a matter of hours after nucleic acid extraction.
Whether using postamplification gel-based analysis, or fluorophore-coupled probes (of which there are several varieties) during amplification, the latest generation of PCR-based assays utilize multiplexing capability. Multiplexed PCR testing requires multiple sets of targetspecific (i.e. pathogen-specific) primers in the same reaction. In systems utilizing postamplification gel-based analysis, these multiplexed systems result in identification of pathogens by their amplicon size, such as the assay system presented in Fujioka et al. [22] . In this work, authors used a pair of multiplexed PCRs coupled to gel analysis to detect nine target genes from the six classes of diarrheagenic E. coli, including stx1, stx2, eaeA, invE, aggR, STh, STp, LT, and astA. In each of the PCRs, primers were positioned and amplicons were designed such that the different genes could be distinguished by size. The authors reported a specificity of 100%, with a limit of detection down to 10 4 CFU/ml for all strains tested amongst 683 E. coli-like isolates tested. A similar system was employed in Rajendran et al. [27] .
Other methods, such as that presented in Guion et al. [23] and Barletta et al. [24] , use a single PCR reaction to detect eight E. coli virulence genes in a single reaction, with each amplified gene product differing in size. However, instead of employing gel analysis, SYBR Green I was included in the PCR reactions and the amplicons were distinguished by melt curve analysis of the amplicons. Using this method, authors were able to correctly classify 89 of 90 diarrheagenic E. coli and 36 of 36 nonpathogenic E. coli (sensitivity 99%, specificity 100%). The multiplexed PCR systems described in the above references were employed as a supplement to culture, with the E. coli strains identified from colonies, whereas many other assays described in Table 1 utilize DNA or RNA obtained directly from stool.
Although the multiplexed methods presented above are able to overcome the problem of only detecting one pathogen at a time, they are only qualitative in nature. We propose that highly sensitive and quantitative methods may be of great use in predicting the causes of diarrhea, operating under the assumption that, especially in cases of mixed pathogen detection, pathogens present at high burden are likely contributors of disease. Addition of sequence-specific, fluorophore-linked probes allows multiplexed PCR systems to become quantitative in nature when standards of known quantities are added to a test run. Use of multiple fluorophores in the same reaction is made possible by thermocycling systems coupled to optical detection packages. The most current real-time PCR thermocyclers are coupled to optical packages that are capable of simultaneously detecting up to six targets through six different emission wavelengths in the same reaction. The study by de Boer et al. [42 ] describes a pair of multiplexed probe-based real-time PCR reactions to detect Salmonella enterica, Campylobacter jejuni, Giardia lambia, STEC, and enteroinvasive E. coli and was used as a molecular prescreening method ahead of culture and microscopy. This molecular screening approach increased the overall pathogen detection rate from 6.4% to 19.2% of samples tested. In an interesting combination of enzyme-linked immunosorbent assay (ELISA) and quantitative PCR, a study by Phillips et al. [34] describes the use of ELISA results from well-defined clinical cases and controls to recommend a cut-off value for quantitative PCR assay results in attributing rotavirus as a cause of infectious intestinal disease. The same group used a similar approach for determining a cut-off in a real-time PCR test for norovirus [35] .
Although not discussed in detail for this review, in addition to PCR and real-time PCR, bead-based systems [32, 41] as well as microarray systems [43] [44] [45] offer simultaneous detection of multiple pathogens through greatly increased multiplexing capability.
Although most of the described tests are developed at research laboratories, PCR platforms have become commonplace in reference and clinical laboratories and commercial entities have also developed tests, some of which have been approved by the US Food and Drug Administration. The most well known of these are targeted against Clostridium difficile and include the Xpert C. difficile from Cepheid, BD GeneOhm system, and Prodesse ProGastro Cd. In particular, the Xpert C. difficile test has been reported to have a sensitivity of between 41 and 460 CFU/swab [46] . Additionally, commercially developed primers and probes are becoming available, such as those from Fast-track Diagnostics (Luxembourg) and Luminex (xTag Gastrointestinal Pathogen Panel).
There are drawbacks to the multiplexed PCR methods. Creation of an assay panel is not always as simple as combining singleplex tests in the same reaction. One common observation during assay development is that prior to assay optimization, the lower limit of detection for a given analyte in a multiplexed reaction is higher (i.e. the test is less sensitive) as compared with the cognate singleplex test. This can be due to oligonucleotides interacting or interfering with one another. In addition, amplification of multiple targets in a single reaction causes the dNTP pool to be drained faster than reactions with single targets, such that there may not be enough dNTPs late into a reaction to amplify a target of low concentration relative to other targets that are present.
This can be especially true of multiplexed PCRs where amplicon sizes are large (200 nt). Although the occurrence of these phenomena vary with each assay or PCR kit used, both oligonucleotide interaction and dNTP drain can potentially become worse as the level of multiplexing goes up, lowering both the sensitivity and reaction efficiency for one or more analytes. Laboratories assembling these types of assays must take these factors into account.
There are also differing costs to implementing these tests. Unmodified oligonucleotide primers are inexpensive and are readily available. SYBR Green and similar intercalating dyes, along with agarose gel systems, are also relatively inexpensive. Conversely, use of probebased real-time PCR drives up costs significantly. This is due to the higher cost of fluorescently-labeled (or otherwise modified) primers and probes, and also the higher cost of thermocycling equipment capable of detecting multiple fluorophores. The cost of the most current real-time PCR cyclers can be as high as $100 000 USD. These costs can affect the availability of these instruments to those laboratories wishing to implement molecular methods.
Although these are today's cutting edge in enteropathogen diagnostics, other technologies are already emerging that could feasibly be in wider use in tomorrow's laboratories. All-in-one type of solutions (nucleic acid extraction, real-time PCR detection, data analysis) are emerging. Closed multiplexed and arrayed singleplex systems such as the FilmArray from Idaho Technologies and the Taqman Array Card system from Applied Biosystems, respectively, are showing promise for detection of multiple pathogens from a single specimen [47, 48] . Emerging technologies are not only aiding in the detection of known pathogens, but are also aiding in the identification of new potential pathogens. Ultra highthroughput sequencing, such as is available from 454 Sequencing (Roche) has been used to identify a novel astrovirus during an outbreak of acute gastroenteritis [49, 50] . Thus the field of molecular diagnostics is rapidly accelerating.
As for understanding the causes of diarrhea, we would emphasize that although these new technologiesparticularly highly multiplexed and quantitative approaches -offer great promise to determining the etiology underlying cases of infectious diarrhea, the increased sensitivity will mean not only increased detection of pathogens in symptomatic cases, but also in nonsymptomatic controls. Indeed, Amar et al. [10] noted that 19% of stool specimens from healthy individuals in this study revealed pathogens when tested with conventional methods, and this increased to 42% of stool specimens when tested with molecular methods. This higher background detection may ultimately lead to the need to quantitate organisms and define a clinical threshold where disease is more likely. Such thresholds are widely used in the viral literature, for instance high plasma viral load of cytomegalovirus predicts disease [51] . In addition, as diagnostics become more sensitive to detect enteropathogens, the causes of diarrhea may become obscured by the presence of multiple pathogens, and proper research design and attention to the clinical-laboratory context will become more important, not less.
Conclusion
Diarrheal diseases are of enormous global health importance [52, 53] and of significant importance in outbreak situations in developed countries. The variety of organisms known to cause diarrhea presents an inherent challenge to the clinician and the laboratory. Newer molecular PCR methods have emerged as sensitive, specific, and potentially quantitative tools that will expand our understanding of the causes of diarrhea when coupled with mindful attention to the clinical setting.
